Topological analysis of the complex formed between neurokinin A and the NK2 tachykinin receptor

Journal of Neurochemistry

Volumn 101, Issue 2, 2007, Pages 506-516

  Zoffmann, Sannah ^a,c   Bertrand, Sonia ^b   Do, Quoc Tuan ^a,d   Bertrand, Daniel ^b   Rognan, Didier ^a   Hibert, Marcel ^a   Galzi, Jean Luc ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^c F HOFFMANN LA ROCHE LTD   (Switzerland)

^d GreenPharma SA   (France)

Author keywords

Fluorescence resonance energy transfer; G protein coupled receptor structure; Peptide conformation; Pharmacology

Indexed keywords

AMINO ACID; ENHANCED GREEN FLUORESCENT PROTEIN; NEUROKININ 2 RECEPTOR; NEUROKININ A; RHODOPSIN; TACHYKININ RECEPTOR;

AMINO TERMINAL SEQUENCE; ARTICLE; COMPUTER MODEL; CONTROLLED STUDY; EMBRYO; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMAN; HUMAN CELL; PHOTOAFFINITY LABELING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; RECEPTOR INTRINSIC ACTIVITY; SITE DIRECTED MUTAGENESIS; STRUCTURE ANALYSIS;

BINDING SITES; BINDING, COMPETITIVE; CELL LINE; CELL MEMBRANE; FLUORESCENCE RESONANCE ENERGY TRANSFER; GREEN FLUORESCENT PROTEINS; HUMANS; MACROMOLECULAR SUBSTANCES; MODELS, MOLECULAR; MOLECULAR STRUCTURE; NERVOUS SYSTEM; NEUROKININ A; NEURONS; PEPTIDES; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, NEUROKININ-2; XANTHENES;

EID: 34047120236     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2007.04473.x     Document Type: Article

References (42)

1. Beaujouan J. C., Saffroy M., Torrens Y. and Glowinski J. (2000) Different subtypes of tachykinin NK(1) receptor binding sites are present in the rat brain. J. Neurochem. 75, 1015-1026.
2. Bhogal N., Donnelly D. and Findlay J. B. (1994) The ligand binding site of the neurokinin 2 receptor Site-directed mutagenesis and identification of neurokinin A binding residues in the human neurokinin 2 receptor. J. Biol. Chem. 269, 27 269-27 274.
3. Bradshaw C. G., Ceszkowski K., Turcatti G., Beresford I. J. and Chollet A. (1994) Synthesis and characterization of selective fluorescent ligands for the neurokinin NK2 receptor. J. Med. Chem. 37, 1991-1995.
4. Bremer A. A., Leeman S. E. and Boyd N. D. (2000) The common C-terminal sequences of substance P and neurokinin A contact the same region of the NK-1 receptor. FEBS Lett. 486, 43-48.
5. Cheng Y.-C. and Prussoff W. H. (1973) Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 per cent inhibition (IC50) of an enzymatic reaction. Biochem. Pharmacol. 22, 3099-3108.
6. Debeljuk L., Ghosh P. and Bartke A. (1990) Neurokinin A levels in the hypothalamus of rats and mice, effects of castration, gonadal steroids and expression of heterologous growth hormone genes. Brain Res. Bull. 25, 717-721.
7. Fraternali F., Do Q. T., Doan B. T., Atkinson R. A., Palmas P., Sklenar V., Safar P., Wildgoose P., Strop P. and Saudek V. (1998) Mapping the active site of factor Xa by selective inhibitors: an NMR and MD study. Proteins 30, 264-274.
8. Gao X. and Wong T. C. (1999) The study of the conformation and interaction of two tachykinin peptides in membrane mimicking systems by NMR spectroscopy and pulsed field gradient diffusion. Biopolymers 50, 555-568.
9. Gembitsky D. S., Murnin M., Otvos F. L., Allen J., Murphy R. F. and Lovas S. (1999) Importance of the aromatic residue at position 6 of [Nle(10)]neurokinin A(4-10) for binding to the NK-2 receptor and receptor activation. J. Med. Chem. 42, 3004-3007.
10. Gether U., Yokota Y., Emonds-Alt X., Breliere J. C., Lowe J. A. d., Snider R. M., Nakanishi S. and Schwartz T. W. (1993a) Two nonpeptide tachykinin antagonists act through epitopes on corresponding segments of the NK1 and NK2 receptors. Proc. Natl Acad. Sci. USA 90, 6194-6198.
11. Gether U., Johansen T. E., Snider R. M., Lowe J. A. d., Nakanishi S. and Schwartz T. W. (1993b) Different binding epitopes on the NK1 receptor for substance P and non- peptide antagonist. Nature 362, 345-348.
12. Giolitti A., Cucchi P., Renzetti A. R., Rotondaro L., Zappitelli S. and Maggi C. A. (2000) Molecular determinants of peptide and nonpeptide NK-2 receptor antagonists binding sites of the human tachykinin NK-2 receptor by site- directed mutagenesis. Neuropharmacology 39, 1422-1429.
13. Griebel G. (1999) Is there a future for neuropeptide receptor ligands in the treatment of anxiety disorders? Pharmacol. Ther. 82, 1-61.
14. Heiden W., Moeckel G. and Brickmann J. (1993) A new approach to analysis and display of local lipophilicity/hydrophilicity mapped on molecular surfaces. J. Comput. Aided Mol. Des. 7, 503-514.
15. Heim R. and Tsien R. Y. (1996) Engineering green fluorescent protein for improved brightness, longer wavelengths and fluorescence resonance energy transfer. Curr. Biol. 6, 178-182.
16. Holst B., Zoffmann S., Elling C. E., Hjorth S. A. and Schwartz T. W. (1998) Steric hindrance mutagenesis versus alanine scan in mapping of ligand binding sites in the tachykinin NK1 receptor. Mol. Pharmacol. 53, 166-175.
17. Huang R. R., Vicario P. P., Strader C. D. and Fong T. M. (1995) Identification of residues involved in ligand binding to the neurokinin-2 receptor. Biochemistry 34, 10 048-10 055.
18. Ilien B., Franchet C., Bernard P., Morisset S., Weill C. O., Bourguignon J. J., Hibert M. and Galzi J. L. (2003) Fluorescence resonance energy transfer to probe human M1 muscarinic receptor structure and drug binding properties. J. Neurochem. 85, 768-778.
19. Kallal L. and Benovic J. L. (2000) Using green fluorescent proteins to study G-protein-coupled receptor localization and trafficking. Trends Pharmacol. Sci. 21, 175-180.
20. Labrou N. E., Mello L. V., Rigden D. J., Keen J. N. and Findlay J. B. (1999) Structure-activity studies on cysteine-substituted neurokinin A analogs. Peptides 20, 795-801.
21. Labrou N. E., Bhogal N., Hurrell C. R. and Findlay J. B. (2001) Interaction of Met297 in the seventh transmembrane segment of the tachykinin NK2 receptor with neurokinin A. J. Biol. Chem. 276, 37 944-37 949.
22. Lakey J. H., Baty D. and Pattus F. (1991) Fluorescence energy transfer distance measurements using site-directed single cysteine mutants. The membrane insertion of colicin A.. J. Mol. Biol. 218, 639-653.
23. Lecat S., Bucher B., Mely Y. and Galzi J. L. (2002) Mutations in the extracellular amino-terminal domain of the NK2 neurokinin receptor abolish cAMP signaling but preserve intracellular calcium responses. J. Biol. Chem. 277, 42 034-42 048.
24. Li Y. M., Marnerakis M., Stimson E. R. and Maggio J. E. (1995) Mapping peptide-binding domains of the substance P (NK-1) receptor from P388D1 cells with photolabile agonists. J. Biol. Chem. 270, 1213-1220.
25. Lordal M., Navalesi G., Theodorsson E., Maggi C. A. and Hellstrom P. M. (2001) A novel tachykinin NK2 receptor antagonist prevents motility-stimulating effects of neurokinin A in small intestine. Br. J. Pharmacol. 134, 215-223.
26. Neugebauer V., Rumenapp P. and Schaible H. G. (1996) The role of spinal neurokinin-2 receptors in the processing of nociceptive information from the joint and in the generation and maintenance of inflammation-evoked hyperexcitability of dorsal horn neurons in the rat. Eur. J. Neurosci. 8, 249-260.
27. Palczewski K., Kumasaka T., Hori T. et al. (2000) Crystal structure of rhodopsin: A G protein-coupled receptor [see comments]. Science 289, 739-745.
28. Regoli D., Rhaleb N. E., Dion S., Tousignant C., Rouissi N., Jukic D. and Drapeau G. (1990) Neurokinin A A pharmacological study. Pharmacol. Res. 22, 1-14.
29. Regoli D., Boudon A. and Fauchere J. L. (1994) Receptors and antagonists for substance P and related peptides. Pharmacol. Rev. 46, 551-599.
30. Renzetti A. R., Catalioto R. M., Criscuoli M., Cucchi P., Ferrer C., Giolitti A., Guelfi M., Rotondaro L., Warner F. J. and Maggi C. A. (1999) Relevance of aromatic residues in transmembrane segments V to VII for binding of peptide and nonpeptide antagonists to the human tachykinin NK(2) receptor. J. Pharmacol. Exp. Ther. 290, 487-495.
31. Saffroy M., Torrens Y., Glowinski J. and Beaujouan J. C. (2003) Autoradiographic distribution of tachykinin NK2 binding sites in the rat brain: comparison with NK1 and NK3 binding sites. Neuroscience 116, 761-773.
32. Sasai Y. and Nakanishi S. (1989) Molecular characterization of rat substance K receptor and its mRNAs. Biochem. Biophys. Res. Commun. 165, 695-702.
33. Sternini C., Anderson K., Frantz G., Krause J. E. and Brecha N. (1989) Expression of substance P/neurokinin A-encoding preprotachykinin messenger ribonucleic acids in the rat enteric nervous system. Gastroenterology 97, 348-356.
34. Turcatti G., Vogel H. and Chollet A. (1995) Probing the binding domain of the NK2 receptor with fluorescent ligands: evidence that heptapeptide agonists and antagonists bind differently. Biochemistry 34, 3972-3980.
35. Turcatti G., Nemeth K., Edgerton M. D., Meseth U., Talabot F., Peitsch M., Knowles J., Vogel H. and Chollet A. (1996) Probing the structure and function of the tachykinin neurokinin-2 receptor through biosynthetic incorporation of fluorescent amino acids at specific sites. J. Biol. Chem. 271, 19 991-19 998.
36. Turcatti G., Zoffmann S., Lowe J. A.III., Drozda S. E., Chassaing G., Schwartz T. W. and Chollet A. (1997) Characterization of nonpeptide antagonist and peptide agonist binding sites of the NK1 receptor with fluorescent ligands. J. Biol. Chem. 272, 21 167-21 175.
37. Van Rhee A. M., Fischer B., Van Galen P. J. and Jacobson K. A. (1995) Modelling the P2Y purinoceptor using rhodopsin as template. Drug Des. Discov. 13, 133-154.
38. Van Schoor J., Joos G. F., Chasson B. L., Brouard R. J. and Pauwels R. A. (1998) The effect of the NK2 tachykinin receptor antagonist SR 48968 (saredutant) on neurokinin A-induced bronchoconstriction in asthmatics. Eur. Respir. J. 12, 17-23.
39. Vollmer J. Y., Alix P., Chollet A., Takeda K. and Galzi J. L. (1999) Subcellular compartmentalization of activation and desensitization of responses mediated by NK2 neurokinin receptors. J. Biol. Chem. 274, 37 915-37 922.
40. Whitehead T. L., McNair S. D., Hadden C. E., Young J. K. and Hicks R. P. (1998) Membrane-induced secondary structures of neuropeptides: a comparison of the solution conformations adopted by agonists and antagonists of the mammalian tachykinin NK1 receptor. J. Med. Chem. 41, 1497-1506.
41. Zhang Y., Lu L., Furlonger C., Wu G. E. and Paige C. J. (2000) Hemokinin is a hematopoietic-specific tachykinin that regulates B lymphopoiesis. Nat. Immunol. 1, 392-397.
42. Zimmer A., Zimmer A. M., Baffi J., Usdin T., Reynolds K., Konig M., Palkovits M. and Mezey E. (1998) Hypoalgesia in mice with a targeted deletion of the tachykinin 1 gene. Proc. Natl Acad. Sci. USA 95, 2630-2635.